H1B Salary Data

Home › Employers › Versiti Blood Health, Inc.

Versiti Blood Health, Inc.: H-1B salaries and sponsorship

Versiti Blood Health, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $59,690.

Applications (LCAs)3
Certified3
Employer addressMilwaukee, WI
H-1B dependent employerNo
Median offered salary$59,690
Middle half of salaries$58,558–$63,936
10th–90th percentile$57,879–$66,484

Does Versiti Blood Health, Inc. sponsor H-1B visas?

Versiti Blood Health, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 10, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Research Scientist II1$68,182
Research Bioinformatics Analyst1$59,690
Research Scientist I1$57,426

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20263$59,690

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Research Scientist I$57,426–$86,140
Level I
Milwaukee, WIJun 10, 2026Nov 5, 2026Certified
Research Bioinformatics Analyst$59,690–$89,536
Level I
Milwaukee, WIMar 23, 2026Jul 20, 2026Certified
Research Scientist II$68,182–$96,818
Level II
Milwaukee, WIMar 6, 2026Apr 26, 2026Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).